"The Latest Breakthrough in Understanding Diabetes Was Made By an Algorithm"
A recent study, published in the journal Science Translational Medicine, demonstrates the broader promise of precision medicine beyond genome sequencing—and in understanding an extremely common disease: Type 2 Diabetes. "This is the first tangible demonstration of precision medicine that could be applied to a more common, complex disease," says study author Joel Dudley, PhD, director of biomedical informatics at the Icahn School of Medicine at Mount Sinai. Learn more.
The Mount Sinai Hospital Ranked Among World’s Best in Newsweek/Statista Rankings
Mar 10, 2026 View All Press Releases
Mount Sinai Health System to Roll Out Microsoft Dragon Copilot
Nov 05, 2025 View All Press Releases
